Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition
Phosphodiesterase type 5 inhibitors (PDE5-Is) have recently emerged as a potential therapeutic strategy for neuroinflammatory, neurodegenerative, and memory loss diseases. Mechanistically, PDE5-Is produce an anti-inflammatory and neuroprotection effect by increasing expression of nitric oxide syntha...
Saved in:
Main Authors: | Christina Alves Peixoto, Ana Karolina Santana Nunes, Ana Garcia-Osta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2015/940207 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Linking Neuroinflammation and Neurodegeneration in Parkinson’s Disease
by: Géraldine Gelders, et al.
Published: (2018-01-01) -
Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain
by: Geeta Ramesh, et al.
Published: (2013-01-01) -
Sildenafil (Viagra) Protective Effects on Neuroinflammation: The Role of iNOS/NO System in an Inflammatory Demyelination Model
by: Catarina Raposo, et al.
Published: (2013-01-01) -
Peyronie's Disease: Evolving Surgical Management and the Role of Phosphodiesterase 5 Inhibitors
by: Tariq F. Al-Shaiji, et al.
Published: (2009-01-01) -
Acid-Sensing Ion Channels as Potential Therapeutic Targets in Neurodegeneration and Neuroinflammation
by: Audrey Ortega-Ramírez, et al.
Published: (2017-01-01)